logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

John M. Adams

university of texas system

38H指数
247论文数
5.2K被引数
收录论文 71
发表时间
logo
Glycemic and non-glycemic benefits of initial triple therapy versus sequential add-on therapy in patients with new-onset diabetes: results from the EDICT study新发糖尿病患者初始三联疗法与序贯加药疗法在降糖和非降糖方面的益处比较：EDICT研究的结果
errBMJ OPEN DIABETES RESEARCH & CARE
IF4.1
err2025-04-27
err0
errOAAI
errAbdul-Ghani, Muhammad; Puckett, Curtiss; Abdelgani, Siham; Merovci, Aurora; Lavrynenko, Olga; Adams, John; Triplitt, Curtis; Defronzo, Ralph A.
err分享
err收藏
Empagliflozin Enhances Hepatic Glucose Production and Reduces Total-Body Norepinephrine Turnover Rate-A Randomized Trial
errDIABETES
IF7.5
err2024-06-14
err0
PREAI
errAbdelgani, Siham; Baskoy, Gozde; Adams, John M., II; Khattab, Ahmed; Defronzo, Ralph A.; Abdul-Ghani, Muhammad
err分享
err收藏
Changes in Beta-Cell Function during Dapagliflozin Therapy in Combination with Exenatide in Type 2 Diabetes Patients (T2D)达格列净联合艾塞那肽治疗2型糖尿病患者 (T2D) 期间 β 细胞功能的变化
errDIABETES
IF7.5
err2024-06-14
err0
PREAI
errDefronzo, Ralph A.; Baskoy, Gozde; Triplitt, Curtis L.; Cersosimo, Eugenio; Solis-Herrera, Carolina; Adams, John M., II; Hansis-Diarte, Andrea A.; Gastaldelli, Amalia; Chavez, Alberto
err分享
err收藏
Empagliflozin Reduces Liver Fat in Diabetic and Nondiabetic Subjects
errMETABOLISM-CLINICAL AND EXPERIMENTAL
IF11.9
err2024-06-01
err0
errOAAI
errAbdelgani, Siham; Khattab, Ahmed; Adams, John; Baskoy, Gozde; Brown, Marissa; Clarke, Geoff; Larvenenko, Olga; DeFronzo, Ralph A.; Abdul-Ghani, Muhammad
err分享
err收藏
Empagliflozin Reduces Liver Fat in Individuals With and Without Diabetes
errDIABETES CARE
IF16.6
err2024-01-31
err2
errOAAI
errAbdelgani, Siham; Khattab, Ahmed; Adams, John; Baskoy, Gozde; Brown, Marissa; Clarke, Geoff; Larvenenko, Olga; DeFronzo, Ralph A.; Abdul-Ghani, Muhammad
err分享
err收藏
The impact of increased hepatic glucose production caused by empagliflozin on plasma glucose concentration in individuals with type 2 diabetes and nondiabetic individuals
errDIABETES OBESITY & METABOLISM
IF5.7
err2023-12-22
err2
PREAI
errAbdelgani, Siham; Khattab, Ahmed; Adams, John; Baskoy, Gozde; Triplitt, Curtis; Defronzo, Ralph A.; Abdul-Ghani, Muhammad
err分享
err收藏
Emergence of a New Glucoregulatory Mechanism for Glycemic Control With Dapagliflozin/Exenatide Therapy in Type 2 Diabetes
errJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
err2023-07-22
err1
PREAI
errCersosimo, Eugenio; Alatrach, Mariam; Solis-Herrera, Carolina; Baskoy, Gozde; Adams, John; Hansis-Diarte, Andrea; Gastaldelli, Amalia; Chavez, Alberto; Triplitt, Curtis; DeFronzo, Ralph A.
err分享
err收藏
Renal Benefit of Dapagliflozin Therapy in Hyperfiltering Type 2 Diabetes Patients
errDIABETES
IF7.5
err2023-06-20
err0
PREAI
errBaskoy, Gozde; Qin, Yuejuan; Cersosimo, Eugenio; Solis-Herrera, Carolina; Adams, John M., III; Defronzo, Ralph A.; Triplitt, Curtis L.
err分享
err收藏
Early Pharmacological Intervention (EPIC) to Preserve Beta-Cell Function in Prediabetes (PreDM)
errDIABETES
IF7.5
err2023-06-20
err0
PREAI
errChavez, Alberto; Merovci, Aurora; Neppala, Sivaram; Moreno, Luis A. Cruz; Baskoy, Gozde; Acosta, Francisca M.; Hansis-Diarte, Andrea A.; Puckett, Curtiss L., Jr.; Adams, John M., III; Abdul-Ghani, Muhammad; Triplitt, Curtis L.; Cersosimo, Eugenio; Defronzo, Ralph A.
err分享
err收藏
Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients
errDIABETES CARE
IF16.6
err2023-03-01
err8
errOAAI
errAbdelgani, Siham; Khattab, Ahmed; Adams, John; Abu-Farha, Mohamed; Daniele, Guisepe; Al-Mulla, Fahd; Del Prato, Stefano; DeFronzo, Ralph A.; Abdul-Ghani, Muhammad
err分享
err收藏
Type 2 diabetes subgroups and response to glucose-lowering therapy: Results from the EDICT and Qatar studies
errDIABETES OBESITY & METABOLISM
IF5.7
err2022-06-29
err6
PREAI
errAbdul-Ghani, Tamam; Puckett, Curtiss; Migahid, Osama; Abdelgani, Siham; Migahed, Ayman; Adams, John; Triplitt, Curtis; DeFronzo, Ralph; Jayyousi, Amin; Abdul-Ghani, Muhammad
err分享
err收藏
Distinct Mechanisms Are Responsible for the Increase in Endogenous Glucose Production and Ketone Formation following Empagliflozin in T2DM Patients
errDIABETES
IF7.5
err2022-06-01
err1
PREAI
errAbdelgani, Siham; Adams, John M., III; Daniele, Giuseppe; Almulla, Fahd; Defronzo, Ralph A.; Abdul-Ghani, Muhammad; Abu-Farha, Mohamed; Del Prato, Stefano
err分享
err收藏
Mechanisms of Dapagliflozin to Reduce Intraglomerular Pressure in Patients with Type 2 Diabetes
errDIABETES
IF7.5
err2022-06-01
err0
PREAI
errBarkhordarian, Maryam; Triplitt, Curtis L.; Solis-Herrera, Carolina; Adams, John M., III; Defronzo, Ralph A.; Cersosimo, Eugenio
err分享
err收藏
Plasma Insulin Is Required for the Increase in Plasma ANGPTL8 Concentration following Glucose Ingestion
errDIABETES
IF7.5
err2022-06-01
err0
PREAI
errAbu-Farha, Mohamed; Abubaker, Jehad; Al Khairi, Irina; Cherian, Preethi T.; Agyin, Christina; Abdelgani, Siham; Alozairi, Ebaa S.; Adams, John M.; Almulla, Fahd; Defronzo, Ralph A.; Abdul-Ghani, Muhammad
err分享
err收藏
Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose
errDIABETES CARE
IF16.6
err2022-03-02
err7
errOAAI
errAlatrach, Mariam; Agyin, Christina; Solis-Herrera, Carolina; Lavryneko, Olga; Adams, John; Gastaldelli, Amalia; Triplitt, Curtis; DeFronzo, Ralph A.; Cersosimo, Eugenio
err分享
err收藏
T2DM Subgroups and Response to Glucose-lowering Therapy: Results from EDICT and Qatar Study
errMETABOLISM-CLINICAL AND EXPERIMENTAL
IF11.9
err2022-03-01
err0
PREAI
errAbdelgani, S.; Abdul-Ghani, T.; Puckett, C.; Migahid, O.; Migahed, A.; Adams, J.; Triplitt, C.; DeFronzo, R. A.; Jayyousi, A.; Abdul-Ghani, M.
err分享
err收藏
Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT)
errDIABETES OBESITY & METABOLISM
IF5.7
err2022-02-09
err21
PREAI
errLavynenko, Olga; Abdul-Ghani, Muhammad; Alatrach, Mariam; Puckett, Curtiss; Adams, John; Abdelgani, Siham; Alkhouri, Naim; Triplitt, Curtis; Clarke, Geoffrey D.; Vasquez, Juan A.; Li, Jinqi; Cersosimo, Eugenio; Gastaldelli, Amalia; DeFronzo, Ralph A.
err分享
err收藏
Insulin Secretion Predicts the Response to Antidiabetic Therapy in Patients With New-onset Diabetes
errJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
err2021-08-03
err5
errOAAI
errAbdelgani, S.; Puckett, C.; Adams, J.; Triplitt, C.; DeFronzo, R. A.; Abdul-Ghani, M.
err分享
err收藏
Bromocriptine-QR (BQR) Ameliorates Immunocyte Pro-Oxidative Stress/Pro-inflammatory (POS/PI) and ER Stress Phenotype in T2DM Subjects
errDIABETES
IF7.5
err2021-06-01
err0
PREAI
errEzrokhi, Michael; Cincotta, Anthony H.; Cersosimo, Eugenio; Adams, John M., II; Alatrach, Mariam; Agyin, Christina; Triplitt, Curtis L.; Cominos, Nicholas; Defronzo, Ralph A.
err分享
err收藏
Insulin secretion is a strong predictor for need of insulin therapy in patients with new-onset diabetes and HbA1c of more than 10%: A post hoc analysis of the EDICT study
errDIABETES OBESITY & METABOLISM
IF5.7
err2021-05-06
err6
errOAAI
errAbdelgani, Siham; Puckett, Curtiss; Adams, John; Triplitt, Curtis; DeFronzo, Ralph A.; Abdul-Ghani, Muhammad
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
R
Ralph A. DeFronzo
H 指数: 129 · 论文数: 672
S
Stefano Del Prato
H 指数: 101 · 论文数: 1.0K
R
Ralph A. DeFronzo
H 指数: 98 · 论文数: 410
A
Amalia Gastaldelli
H 指数: 96 · 论文数: 630
K
Kenneth Cusi
H 指数: 95 · 论文数: 380
查看更多